Page 45 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Accesswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. Exelixis Announces Positive Findings at ASCO GU for CABOMETYX® (cabozantinib) in Patients with Brain Metastases from Renal Cell Carcinoma February 8, 2021 GMT ALAMEDA, Calif.--(BUSINESS WIRE)--Feb 8, 2021-- Exelixis, Inc. (NASDAQ: EXEL) today announced results from a retrospective analysis evaluating CABOMETYX ® (cabozantinib) activity in brain metastases in patients with renal cell carcinoma (RCC). ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of ... Passage BioFebruary 8, 2021 GMT - Phase 1/2 trial expected to commence in first half of 2021  - Company has three INDs cleared for rare monogenic CNS disorders PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformativ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Grapheal Raises EUR1.9 Million to Advance Development of Embedded Biosensing Technology and Application in Digital COVID Testing and Wound Monitoring February 9, 2021 GMT GRENOBLE, France--(BUSINESS WIRE)--Feb 9, 2021-- Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel ... Emerald Health PharmaceuticalsFebruary 9, 2021 GMT Data published in peer-reviewed journal, Molecular and Cellular Neuroscience show neuroprotective and neurogenic activity of proprietary product candidate, EHP-102 SAN DIEGO, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or th...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 ... AzurRx BioPharma, Inc.February 9, 2021 GMT Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development o...